Probe ID | Genomic location* | Gene name | Estimate (SE)† | P value | q value |
Decreased methylation at follow-up | |||||
cg11835347 | chr1: 113248232 | RHOC | −0.054 (0.011) | 1.09E-05 | 0.035 |
cg16265542 | chr1: 152814831 | LCE6A | −0.058 (0.012) | 8.23E-06 | 0.032 |
cg21721331 | chr1: 157670877 | FCRL3 | −0.061 (0.013) | 2.13E-05 | 0.043 |
cg02928345 | chr1: 224411698 | NA | −0.065 (0.014) | 8.08E-06 | 0.032 |
cg15591386 | chr1: 76265299 | MSH4 | −0.054 (0.012) | 2.67E-05 | 0.044 |
cg03740864 | chr10: 120660492 | NA | −0.054 (0.01) | 8.46E-07 | 0.023 |
cg02884943 | chr10: 72725905 | NA | −0.059 (0.013) | 1.71E-05 | 0.040 |
cg10967759 | chr10: 73555025 | CDH23 | −0.071 (0.015) | 7.81E-06 | 0.032 |
cg23024158 | chr10: 78011952 | C10orf11 | −0.051 (0.011) | 2.36E-05 | 0.043 |
cg03762984 | chr11: 29355671 | NA | −0.081 (0.016) | 4.70E-06 | 0.027 |
cg01078446 | chr12: 115113212 | TBX3 | −0.05 (0.01) | 1.31E-05 | 0.037 |
cg18956104 | chr12: 119621039 | HSPB8 | −0.059 (0.012) | 3.68E-06 | 0.026 |
cg12248652 | chr12: 132703589 | GALNT9 | −0.056 (0.011) | 3.64E-06 | 0.026 |
cg02121135 | chr14: 24858912 | NA | −0.073 (0.015) | 4.82E-06 | 0.027 |
cg02938807 | chr14: 63785523 | GPHB5 | −0.069 (0.015) | 2.72E-05 | 0.044 |
cg02428178 | chr15: 49104237 | CEP152 | −0.053 (0.011) | 9.69E-06 | 0.034 |
cg04245616 | chr15: 59543693 | MYO1E | −0.072 (0.017) | 4.20E-05 | 0.048 |
cg06297541 | chr16: 22384949 | CDR2 | −0.053 (0.011) | 1.35E-05 | 0.037 |
cg12891543 | chr16: 53958626 | FTO | −0.052 (0.012) | 3.09E-05 | 0.045 |
cg07280206 | chr16: 56554249 | BBS2 | −0.063 (0.01) | 1.61E-07 | 0.016 |
cg03432196 | chr18: 9643805 | NA | −0.063 (0.013) | 6.43E-06 | 0.029 |
cg19995259 | chr19: 53795827 | BIRC8 | −0.056 (0.013) | 3.53E-05 | 0.046 |
cg16903817 | chr2: 114655480 | ACTR3 | −0.09 (0.019) | 7.62E-06 | 0.031 |
cg16262572 | chr2: 122479703 | NIFK-AS1 | −0.052 (0.01) | 2.53E-06 | 0.026 |
cg25296103 | chr2: 145268533 | ZEB2 | −0.06 (0.012) | 5.25E-06 | 0.028 |
cg00441550 | chr20: 29955998 | DEFB118 | −0.06 (0.013) | 2.21E-05 | 0.043 |
cg16145176 | chr21: 25596030 | NA | −0.06 (0.013) | 2.32E-05 | 0.043 |
cg17885233 | chr3: 132450221 | NPHP3-AS1 | −0.051 (0.011) | 1.84E-05 | 0.041 |
cg13166622 | chr3: 150904863 | MED12L | −0.081 (0.016) | 1.64E-06 | 0.025 |
cg03520471 | chr3: 97753623 | GABRR3 | −0.054 (0.012) | 2.30E-05 | 0.043 |
cg16350196 | chr4: 137426420 | NA | −0.052 (0.011) | 2.36E-05 | 0.043 |
cg20300412 | chr4: 65749341 | NA | −0.064 (0.014) | 3.07E-05 | 0.045 |
cg21359538 | chr4: 76440740 | RCHY1 | −0.062 (0.014) | 3.05E-05 | 0.045 |
cg03498271 | chr5: 38427885 | EGFLAM | −0.055 (0.012) | 1.12E-05 | 0.036 |
cg06887251 | chr5: 67576008 | PIK3R1 | −0.054 (0.012) | 2.83E-05 | 0.045 |
cg10874300 | chr5: 67588385 | PIK3R1 | −0.066 (0.011) | 4.36E-08 | 0.014 |
cg04708601 | chr6: 101880078 | GRIK2 | −0.051 (0.011) | 2.19E-05 | 0.043 |
cg24105728 | chr6: 13007033 | PHACTR1 | −0.054 (0.011) | 6.61E-06 | 0.029 |
cg18742528 | chr6: 13053520 | PHACTR1 | −0.055 (0.011) | 5.83E-06 | 0.029 |
cg27509293 | chr6: 14919597 | NA | −0.057 (0.013) | 3.36E-05 | 0.046 |
cg08188318 | chr6: 34984953 | ANKS1A | −0.093 (0.02) | 1.24E-05 | 0.037 |
cg10420626 | chr6: 43741154 | VEGFA | −0.057 (0.013) | 2.72E-05 | 0.044 |
cg00325383 | chr6: 85404488 | LOC102724201 | −0.057 (0.012) | 9.43E-06 | 0.034 |
cg19989663 | chr7: 115981565 | NA | −0.056 (0.013) | 4.46E-05 | 0.050 |
cg03083251 | chr7: 135408513 | SLC13A4 | −0.076 (0.016) | 6.70E-06 | 0.029 |
cg12018852 | chr7: 138777233 | ZC3HAV1 | −0.052 (0.01) | 4.63E-06 | 0.027 |
cg05753918 | chr7: 14899040 | NA | −0.065 (0.013) | 2.32E-06 | 0.026 |
cg04946588 | chr7: 86271783 | GRM3 | −0.052 (0.011) | 1.66E-05 | 0.040 |
cg21637741 | chr8: 69834365 | LINC01592 | −0.052 (0.011) | 2.40E-05 | 0.043 |
cg15728672 | chr8: 89189971 | MMP16 | −0.059 (0.011) | 1.64E-06 | 0.025 |
cg01761595 | chr8: 9821723 | NA | −0.069 (0.015) | 1.70E-05 | 0.040 |
cg14611112 | chr9: 139643351 | LCN6 | −0.053 (0.011) | 6.49E-06 | 0.029 |
cg03779244 | chrX: 56771607 | LINC01420 | −0.085 (0.016) | 1.60E-06 | 0.025 |
Increased methylation at follow-up | |||||
cg19190900 | chr2: 37553621 | NA | 0.053 (0.012) | 2.23E-05 | 0.043 |
cg25229577 | chr3: 58367583 | PXK | 0.062 (0.013) | 6.81E-06 | 0.029 |
cg00367499 | chr5: 170634447 | RANBP17 | 0.062 (0.014) | 3.81E-05 | 0.048 |
cg14396995 | chr7: 42278089 | GLI3 | 0.06 (0.013) | 1.86E-05 | 0.041 |
cg21156439 | chr9: 94716496 | NA | 0.051 (0.011) | 1.57E-05 | 0.039 |
cg00625110 | chr16: 53741731 | FTO | 0.069 (0.014) | 3.35E-06 | 0.026 |
cg01154210 | chr21: 27493310 | APP | 0.102 (0.022) | 1.63E-05 | 0.039 |
NA means the CpG site is not within a gene or within a known feature (eg, promoter) of a specific gene.
*Genomic location is according to genome build GRCh37/hg19.
†Effect estimates represent the proportion of methylation difference at follow-up compared with baseline, adjusted for batch, cell type estimates, Hispanic ethnicity, estimated smoking pack-years and a random intercept for individual to account for the repeated sampling design.